Leverage PK data in PharmaPendium to inform drug development strategies

Presented by

Marnix Wieffer

About this talk

Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more successful drug development and regulatory approval strategies. Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more successful drug development and regulatory approval strategies. Join solution marketing manager Dr. Marnix Wieffer for this webinar, where he will discuss how to leverage extracted pharmacokinetic data from literature and FDA/EMA Drug Approval documents to make better-informed decisions on which drugs have the most potential to succeed in clinical development. Using PharmaPendium we will •Retrieve detailed information on PK parameters on approved drugs •Retrieve all data on PK parameter of interest (for example Cmax) on drug acting on the same target I am working on •Investigate what is the best translational model to assess Serum protein binding •And much more

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (80)
Subscribers (10986)
Realize the potential of data-driven drug discovery and development with solutions that help you increase research efficiency and ensure a thriving R&D pipeline.